| Literature DB >> 35456510 |
Ewa Boniewska-Bernacka1, Anna Pańczyszyn1, Jacek Hobot1, Piotr Donizy2, Zbigniew Ziembik3, Anna Goc1, Marian Klinger1.
Abstract
The length of telomeres (TLs) that protect chromosome ends may reflect the age of cells as well as the degree of genetic material damage caused by external factors. Since leukocyte telomere length is associated with cardiovascular diseases, the aim of this study was to evaluate whether leukocyte TL reflects femoral artery wall telomeres of patients with atherosclerosis and lower limb ischemia. Samples of femoral artery wall and blood were collected from 32 patients qualified to surgical revascularization. The analysis included blood and artery wall telomere length measurement and biochemical parameters. The study indicated that there was a moderate correlation between artery wall TL and leukocyte TL. Leukocyte TL was, on average, two times shorter than artery wall TL and correlated with the number of white blood cells. In turn, artery TL was impacted by total cholesterol level. The results suggest that the length of leukocyte telomeres may reflect artery wall TL and indirectly reflect the processes taking place in the artery wall in patients with atherosclerosis.Entities:
Keywords: atherosclerosis; cholesterol; inflammation markers; telomere length
Mesh:
Year: 2022 PMID: 35456510 PMCID: PMC9030852 DOI: 10.3390/genes13040704
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.141
Sequence of primers and oligomers used in the qPCR.
| Primer/Oligomer | Sequence | Reference |
|---|---|---|
| Primer TeloF | CGGTTTGTTTGGGTTTGGGTTTGGGTTTGGG TTTGGGTT | [ |
| Primer TeloR | GGCTTGCCTTACCCTTACCCTTACCC TTACCCTTACCCT | |
| Primer Albu | CGGCGGCGGGCGGCGCGGGCTGGGCGGaaatgctgcacagaatccttg | [ |
| Primer Albd | GCCCGGCCCGCCGCGCCCGTCCCGCCGgaaaagcatggtcgcctgtt | |
| Oligomer tel | TTAGGGTTAGGGTTAGGGTTAGGGTTAGGGTTAGGGTTAGGGTTAGGGTTAGGGTTAGGGTTAGGGTTAGGGTTAGGG | [ |
| Oligomer alb | CAGAGTCACCAAATGCTGCACAGAATCCTTGGTGAACAGGCGACCATGCTTTTCAGCTCTGGAA | [ |
Characteristics of the study group.
| Variable | Mean ± SD/Median (Q1; Q3) | |
|---|---|---|
| Age, years | 32 | 67.63 ± 8.36 |
| Leukocyte telomeres | 32 | 2381.63 ± 897.96 |
| Artery wall telomeres | 32 | 5131.72 ± 1 884.15 |
| Ratio (artery wall TL/leukocyte TL) | 32 | 2.34 ± 0.88 |
| Glucose, mg/dL | 28 | 108.50 (95.25; 133.75) |
| Cholesterol, mg/dL | 27 | 157.00 (135.50; 218.00) |
| CRP, mg/L | 31 | 3.05 (1.30; 8.27) |
| LDL, mg/dL | 9 | 58.20 (51.70; 95.00) |
| WBCs, 103/uL | 32 | 7.86 ± 2.17 |
| HGB, g/dL | 32 | 13.50 (12.25; 14.70) |
| Neutrophils, 103/µL | 23 | 4.14 (3.55; 5.52) |
| Lymphocytes, 103/µL | 23 | 2.09 ± 0.72 |
| Platelets, 103/µL | 32 | 239.22 ± 73.48 |
Figure 1Correlation between leukocyte TL and (A) artery wall TL (Pearson’s correlation, R = 0.3751; p = 0.034); (B) WBCs (Pearson’s correlation, R = 0.5608; p = 0.0008); (C) neutrophils (Pearson’s correlation, R = 0.6985; p = 0.0002); (D) total cholesterol (Pearson’s correlation, R = 0.5093; p = 0.049).
Univariate linear regression for leukocyte telomere length.
| β | 95% CI | Std. β |
| |
|---|---|---|---|---|
| Age, years | −25.44 | −64.36 to 13.49 | −0.24 | 0.192 |
| Glucose, mg/dL | 4.52 | −0.70 to 9.74 | 0.34 | 0.087 |
|
|
|
|
|
|
| CRP, mg/L | 18.02 | −15.98 to 52.03 | 0.20 | 0.287 |
| LDL, mg/dL | −5.10 | −18.81 to 8.60 | −0.31 | 0.408 |
|
|
|
|
|
|
| HGB, g/dL | −8.80 | −23.49 to 5.89 | −0.22 | 0.231 |
|
|
|
|
|
|
| Lymphocytes, 103/uL | 116.30 | −486.46 to 719.12 | 0.09 | 0.692 |
| Platelets, 103/uL | 2.68 | −1.77 to 7.12 | 0.02 | 0.229 |
β—beta coefficient in the regression model; Std. β—standardized beta; CI—confidence interval.
Univariate regression for artery telomeres length.
| β | 95% CI | Std. β |
| |
|---|---|---|---|---|
| Age, years | −75.22 | −154.46 to 4.02 | −0.33 | 0.062 |
| Glucose, mg/dL | −5.20 | −17.15 to 6.54 | −0.18 | 0.379 |
|
|
|
|
|
|
| CRP, mg/L | −6.24 | −79.38 to 66.89 | −0.03 | 0.863 |
| LDL, mg/dL | 5.93 | −30.48 to 42.34 | 0.17 | 0.712 |
| WBCs, 103/uL | 87.35 | −234.71 to 409.40 | 0.10 | 0.584 |
| HGB, g/dL | −18.15 | −48.99 to 12.69 | −0.21 | 0.239 |
| Neutrophils, 103/uL | 153.50 | −254.65 to 561.75 | 0.17 | 0.443 |
| Lymphocytes, 103/uL | 855.20 | −284.19 to 1994.60 | 0.33 | 0.134 |
| Platelets, 103/uL | 5.17 | −4.20 to 14.53 | 0.20 | 0.269 |
β—beta coefficient in regression model; Std. β—standardized beta; CI—confidence interval.
Figure 2Correlation between artery wall TL and total cholesterol (Pearson’s correlation, R = 0.6985; p = 0.0002).